d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy: A Cohort Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Normal D-dimer levels after withdrawal of anticoagulant therapy are associated with a reduced risk for recurrence in patients with unprovoked venous thromboembolism (VTE) and may justify stopping treatment. OBJECTIVE: To determine whether patients with a first unprovoked VTE and negative D-dimer test result who stop anticoagulant therapy have a low risk for recurrence. DESIGN: Prospective management study with blinded outcome assessment. (ClinicalTrials.gov: NCT00720915). SETTING: 13 university-affiliated clinical centers. PATIENTS: 410 adults aged 75 years or younger with a first unprovoked proximal deep venous thrombosis or pulmonary embolism who had completed 3 to 7 months of anticoagulant therapy. INTERVENTION: Anticoagulant therapy was stopped if D-dimer test results were negative and was not restarted if results were still negative after 1 month. MEASUREMENTS: Recurrent VTE during an average follow-up of 2.2 years. RESULTS: In 319 patients (78%) who had 2 negative D-dimer results and did not restart anticoagulant therapy, rates of recurrent VTE were 6.7% (95% CI, 4.8% to 9.0%) per patient-year overall (42 of 319), 9.7% (CI, 6.7% to 13.7%) per patient-year in men (33 of 180), 5.4% (CI, 2.5% to 10.2%) per patient-year in women with VTE not associated with estrogen therapy (9 of 81), and 0.0% (CI, 0.0% to 3.0%) per patient-year in women with VTE associated with estrogen therapy (0 of 58) (P = 0.001 for the 3-group comparison). LIMITATIONS: Imprecision in female subgroups. Results may not be generalizable to different D-dimer assays from the one used in the study. CONCLUSION: The risk for recurrence in patients with a first unprovoked VTE who have negative D-dimer results is not low enough to justify stopping anticoagulant therapy in men but may be low enough to justify stopping therapy in women. PRIMARY FUNDING SOURCE: Canadian Institutes of Health Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
d -Dimer Testing to Determine the Duration of Anticoagulation Therapy
Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054444 · Cited by 622
Iorio, A., Kearon, C., Filippucci, E., Marcucci, M., Macura, A., Pengo, V., Siragusa, S., & Palareti, G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.367 · Cited by 385
Self-citationEffect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.
McRae, S., Tran, H., Schulman, S., Ginsberg, J., & Kearon, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69110-1 · Cited by 289
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R. C., & Iorio, A. (2011) · BMJ · doi:10.1136/bmj.d813 · Cited by 278
Self-citationDouketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R. C., & Iorio, A. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00009 · Cited by 175
Self-citationBAGLIN, T., BAUER, K., DOUKETIS, J., BULLER, H., SRIVASTAVA, A., & JOHNSON, G. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04662.x · Cited by 137
Self-citation
Cited by
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Self-citationDeep vein thrombosis and pulmonary embolism
Di Nisio, M., van Es, N., & Büller, H. R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30514-1 · Cited by 994
Mazzolai, L., Aboyans, V., Ageno, W., Agnelli, G., Alatri, A., Bauersachs, R., Brekelmans, M. P. A., Büller, H. R., Elias, A., Farge, D., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx003 · Cited by 402
“However, using moderately sensitive D-dimer assay during and 30 days after stopping anticoagulation, these results were not confirmed in men, and in women with VTE not associated with oestrogen treatment.(75) Similarly, when measurements were repeated using a quantitative assay, D-dimer testing failed to identify subg…”
ResultVenous Thromboembolism: Advances in Diagnosis and Treatment
Tritschler, T., Kraaijpoel, N., Le Gal, G., & Wells, P. S. (2018) · JAMA · doi:10.1001/jama.2018.14346 · Cited by 357
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
Stevens, S. M., Woller, S. C., Bauer, K. A., Kasthuri, R., Cushman, M., Streiff, M., Lim, W., & Douketis, J. D. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1316-1 · Cited by 345
Self-citation
Metadata
- Authors
- Kearon, C., Spencer, F. A., O'Keeffe, D., Parpia, S., Schulman, S., Baglin, T., Stevens, S. M., Kaatz, S., Bauer, K. A., Douketis, J. D., Lentz, S. R., Kessler, C. M., Moll, S., Connors, J. M., Ginsberg, J. S., Spadafora, L., Julian, J. A., & for the d-Dimer Optimal Duration Study Investigators*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-01-06
- Volume
- 162
- Issue
- 1
- Pages
- 27-34
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2084430347
- Cited by
- 145
- References
- 7
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy: A Cohort Study. https://app.cochat.ai/papers/10.7326/m14-1275
- The paper
- Kearon, C., Spencer, F. A., O'Keeffe, D., Parpia, S., Schulman, S., Baglin, T., Stevens, S. M., Kaatz, S., Bauer, K. A., Douketis, J. D., Lentz, S. R., Kessler, C. M., Moll, S., Connors, J. M., Ginsberg, J. S., Spadafora, L., Julian, J. A., & for the d-Dimer Optimal Duration Study Investigators*. (2015). d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy: A Cohort Study. Annals of Internal Medicine. https://doi.org/10.7326/m14-1275
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.